Milgamma against diabetic neuropathy
Milgamma is a medication prescribed to patients with diabetes. It is used for the control and treatment of certain conditions related to diabetes such as diabetic neuropathy, diabetic retinopathy, and nephropathy. It is a combination drug containing three active substances – benfotiamine, cyanocobalamin, and pyridoxine. It was first formulated and manufactured by Japanese pharmaceutical manufacturer Sankyo, though now other manufacturers have also started marketing this drug.
All three active substances in Milgamma are derivations of vitamin B; benfotiamine is the man-made form of vitamin B1 or thiamine; cyanocobalamin is a form of vitamin B12, while pyridoxine is metabolized in the body to give vitamin B6. In addition to treating conditions such as diabetic neuropathy related to diabetes, Milgamma is also used for the treatment of a number of different diseases of the nervous system. These include neuralgia, myodynia, radicular syndrome, herpes zoster, and deficiencies of vitamins B1 and B6.
Diabetic neuropathy, retinopathy, and nephropathy are all complications of diabetes caused on account of extended hyperglycemia or high blood sugar levels. This hyperglycemia leads to deposition of glucose in the muscles, which then percolates into the cells and damages them. Such damage can lead to life threatening conditions if not detected and treated on time. Clinical studies have shown that the active substances in Milgamma work in the body by inhibiting the build-up of glucose in the muscles and cells.
All three ingredients of Milgamma are also used individually as dietary supplements for the treatment of diabetic patients. While it is pending official approval from the FDA, Milgamma is already in use in the US and in many other countries. It is primarily used as a dietary supplement and is well-accepted and tolerated. As it is largely a vitamin-based drug, Milgamma is non-toxic and has not been found to have any major side-effects.
Most studies have shown that the side-effects of Milgamma are restricted to skin rashes, itching, hives, redness, excessive sweating, and dizziness. Some patients have also complained of irregular heartbeats, though it is a rare occurrence. Milgamma is generally considered to be safe for the use of pregnant women and breast-feeding mothers, though its use must be supervised by trained medical practitioners and should be strictly as per their guidance.
While the drug is known to pass into breast milk, its effect on the baby has not been fully studied. So breast-feeding mothers must take this drug with care. Though well-tolerated, Milgamma is not advisable for patients who have an allergy to any of its ingredients or who suffer from severe liver diseases.
Milgamma is available in various dosage forms including tablets, dragee, and injections. It must be used strictly in the form and dosage strength prescribed by your doctor. Depending on the severity of your diabetes or diabetic neuropathy, you might be required to take up to 100mg of Milgamma daily. However, for pregnant women, it is advisable to not exceed 25mg in daily dosage.
Source by Isoprinosine123